![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference
May 12, 2015 16:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 12, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference
May 06, 2015 16:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 6, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 40th Annual Health Care Conference
May 01, 2015 16:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 1, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Reports First Quarter 2015 Financial Results
May 01, 2015 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 1, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2015.
For the first quarter...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting
April 20, 2015 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 20, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting
April 17, 2015 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 17, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Conference Call Details Regarding FDA Approval for Glatopa(TM) (glatiramer acetate injection)
April 16, 2015 12:53 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 16, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
April 16, 2015 12:30 ET
|
Momenta Pharmaceuticals
First generic multiple sclerosis product approved in the United States
Approval triggers $10 million milestone payment to Momenta
CAMBRIDGE, Mass., April 16, 2015 (GLOBE NEWSWIRE) --...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast
April 15, 2015 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 15, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialylated IVIg Drug Candidate in PNAS
March 02, 2015 15:34 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...